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INTRODUCTION
The metabolic processes and chemical alterations necessary for vitamin D to fulfill its role in regulating calcium homeostasis have been clarified dramatically by a series of discoveries made within the past decade. Several recent reviews serve as excellent sources for those interested in a complete discussion of vitamin D metabolism and mechanism of action (1) (2) (3) .
Under, normal circumstances, only small amounts of unchanged vitamin D circulate in the bloodstream.
Unneeded vitamin D appears to be either stored as the unchanged molecule in adipose tissue (4) or metabolized and excreted. Vitamin D needed to fulfill its physiologi-cal roles must first undergo chemical alteration. The initial, obligatory step in vitamin D metabolism is hydroxylation at carbon-25 on the side chain.
Normally, the majority of circulating vitamin D is initally taken up by the liver where it can be converted to 25-hydroxyvitamin D3 (25-OH-Ds).' Fig. 1 is a summary of data from several sources (5) (6) (7) (8) ; it graphically illustrates the time sequence of the metabolic pools of vitamin D3 in the liver and plasma of vitamin D-deficient rats after a single intravenous dose of radioactive vitamin Da. The initial rapid disappearance of 'H from plasma corresponds with a large uptake of radioactivity by the liver. At approximately 2-4 h, the disappearance of ['H]plasma is interrupted by a rebound in radioactivity which is associated with a drop in liver radioactivity. This rebound can be accounted for by the appearance of 25-OH-D3 in the plasma compartment.
Based on such data, Ponchon and DeLuca first postulated that the liver is the major site of vitamin D8 conversion to 25-OH-D3 (5) . Later, they showed that the isolation of the liver from the circulation of vitamin D-deficient rats almost completely eliminates their ability to produce 25-OH-D3 (6) . However, the possibility of some liver participation in the production of the small amount of 25-OH-Ds found in the plasma could not [15] .) The rats were then allowed to recover from the ether anesthesia and were maintained by frequent glucose administration. The tail vein cannulation recommended by Bollman and Van Hook (13) was not used; instead, all the rats (experimental and sham operated) were given an initial 2.5-ml intraperitoneal injection of 10%o glucose followed by 1.0-ml hourly injections. This regimen of glucose administration was adequate for maintaining the hepatectomized rats for up to a 12-h experimental period. Those rats that failed to survive for the entire experimental period died due to bleeding or complications, which at autopsy could be directly related to surgical technique and not to hypoglycemia. The percentage of hepatectomy survivors steadily increased as the required surgical procedures were mastered.
At the end of the maintenance period the experimental rats were sacrificed by decapitation. The exposed blood vessels were heparinized and as much blood as possible was collected in a heparinized centrifuge tube. As indicated, appropriate organs were dissected out and stored frozen at -20'C until used for analysis. Tissue lipids were extracted using the modified Bligh and Dyer (16) method described by Lund and DeLuca (17) Fig. 2B. 1 .4% of the administered radioactivity chromatographed in the same region as 25-OH-D3, and 49.1% chromatographed in the same region as unchanged vitamin D3.
The fact that over 50% of the initial vitamin D3 dose is in the plasma compartment of hepatectomized rats after 6 h indicates that the rat without a liver does not remove vitamin D3 from its blood very efficiently. An overview of the overall disappearance of a 10-IU intravenous dose of vitamin D3 in vitamin D-deficient rats without a liver is shown in Fig. 2 . The Sephadex LH-20 profile of the plasma extract from a hepatectomized rat 6 h after an intrajugular dose of 10-IU vitamin D3 (Fig.  2B ) is compared with the profiles 4 and 12 h after a similar dose. Notice that at 12 h (Fig. 2C) over 30% of the original radioactivity remains in the plasma in a peak which chromatographs in the same region as unchanged vitamin D3, while 1.5% of the original radioactivity in the plasma chromatographs similarly to 25-OH-Ds. After 4 h ( Fig. 2A) The previous results ( Fig. 2 and Tables I and II) indicate that in hepatectomized rats the normal sequence of vitamin D3 metabolism is dramatically altered. In Fig. 3 the chromatographic profiles of plasma lipid extracts from sham-operated controls which had survived the alterations in visceral circulation produced by the first stage of the hepatectomy operations are illustrated. Both 6 and 12 h after an intrajugular dose of 10 IU 3H-vitamin D3, the vitamin D-deficient rats which retained their livers (with a somewhat altered circulation) were able to approximate the normal vitamin D3 plasma metabolic pattern as summarized in Fig. 1 . These rats clearly exhibited a more rapid reduction in circulating vitamin D3 and a greater production of 25- OH-Da-like material than the corresponding hepatectomized rats (Fig. 2B and C) . Vitamin D-deficient rats do appear to be able to produce a 25-OH-D3-like metabolite in the absence of their livers. Fig. 4 presents data which indicate that the production of a 25-OH-Ds-like metabolite in hepatectomized rats is inhibited by a 10-IU predose of unlabeled vitamin Da (compare Fig. 4B with Fig. 2B ) just as it does to intact vitamin D-deficient animals (compare Fig. 4A with Fig. 3A) . Thus, the 25-OH-Ds-like material produced by rats without a liver appears to be subject to feedback inhibition analogous to the previously studied hepatic vitamin Da-25-hydroxylase system (10, 11) .
The vitamin D3 metabolite extracted from hepatectomized rat plasma which chromatographs like 25-OH-Da on Sephadex LH-20 in part co-chromatographs with synthetically prepared "C-labeled 25-OH-D3 on a hydroxyalkoxypropyl Sephadex chromatographic system. which the tritium containing 25-OH-Ds metabolite, isolated after Sephadex LH-20 chromatography of hepatectomized rat plasma lipid extract, was combined with synthetically prepared "C-labeled 25-OH-Ds. Notice that over 84% of the "C-labeled 25-OH-D3 was recovered in a symmetrical 25-OH-Ds peak. Approximately 58% of the tritium-containing metabolite obtained from Sephadex LH-20 chromatography co-chromatographs precisely with the known "C-labeled 25-OH-Ds peak. (22) . These possibilities all merit further investigation.
In the present study the possible appearance of 25-OH-D3 in small intestine and kidney was also examined. In the intact animal the expected pattern of 25-hydroxylation in the liver followed by 1- (12, 23) . Fur-thermore, the hepatectomized rats survived for 12 h, and it would appear that at least during the first few hours when significant 25-hydroxylation should have occurred, the health criticism should be less valid.
The nature of the extrahepatic 25-hydroxylation is unknown. Since it is apparently inhibited by a predose of vitamin D3, it would appear to be similar to the hepatic microsomal 25-hydroxylation (11) . However, at least some of it may be carried out by the same system which hydroxylates cholesterol and dihydrotachysterol (24) .
Unfortunately, the precise physiological significance of the extrahepatic 25-hydroxylation cannot be firmly ascertained. The present study, however, strongly supports the major importance of the liver in the metabolism of vitamin D3 in general and 25-hydroxylation in particular at least in mammals.
